Edwards Lifesciences EW
NYSE EW
$84.40 -2.37 (-2.73%)
As of: Sep 11, 2026 · 3:59 PM EDT

Edwards Lifesciences (EW) Total Debt Growth (3y) (2012 - 2026)

Analysis

Edwards Lifesciences (EW) Total Debt Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (3y) (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn 24.63%
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn -
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn 4.06%
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn 4.89%
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn 11.72%
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn 0.11%
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn 252.76%
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn -
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn -10.56%
10 Zimmer Biomet Holdings 18.00 Bn 17.59 Bn 1.54 Bn 9.42%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.11%
Mar 31, 2026 0.11%
Dec 31, 2025 0.11%
Sep 30, 2025 0.11%
Jun 30, 2025 0.11%
Mar 31, 2025 0.11%
Dec 31, 2024 0.11%
Sep 30, 2024 0.11%
Jun 30, 2024 0.11%
Mar 31, 2024 0.11%
Dec 31, 2023 0.11%
Sep 30, 2023 0.11%
Jun 30, 2023 0.11%
Mar 31, 2023 0.11%
Dec 31, 2022 0.11%
Sep 30, 2022 0.11%
Jun 30, 2022 0.11%
Mar 31, 2022 0.11%
Dec 31, 2021 0.11%
Sep 30, 2021 -20.69%